Search research articles
Contact Us
Filters
Showing results (1-10 of 202) with videos related to
Page
of 21
Sort By:
Pacing and Clinical Electrophysiology : PACE
|
November 25, 2010
Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?
James A Reiffel
The Journal of Innovations in Cardiac Rhythm Management
|
June 5, 2020
Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
James A Reiffel
Journal of Electrocardiology
|
May 16, 2020
Sinus node depolarization - Present during all sinus rhythms but never seen on the 12-lead ECG: An illustrative case-report that provides its recording
James A Reiffel
Journal of the American College of Cardiology
|
September 1, 2022
Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome
James A Reiffel
The American Journal of Cardiology
|
May 12, 2018
Back to the Future-New Data Confirms Old Data
James A Reiffel
American Heart Journal
|
May 1, 2022
The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy
James A Reiffel
JAMA
|
April 23, 2009
Equivalence of generic and brand-name drugs for cardiovascular disease
James A Reiffel
Journal of Atrial Fibrillation
|
May 13, 2017
GIANT Flutter Waves in ECG Lead V1: a Marker of Pulmonary Hypertension
James A Reiffel
Journal of Atrial Fibrillation
|
May 13, 2017
The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn
James A Reiffel
Current Opinion in Cardiology
|
December 23, 2003
Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?
James A Reiffel
Page
of 21
Search research articles
Search
Showing results (1-10 of 202) with videos related to
Sort By:
Page
of 21
Pacing and Clinical Electrophysiology : PACE
|
November 25, 2010
Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?
James A Reiffel
The Journal of Innovations in Cardiac Rhythm Management
|
June 5, 2020
Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
James A Reiffel
Journal of Electrocardiology
|
May 16, 2020
Sinus node depolarization - Present during all sinus rhythms but never seen on the 12-lead ECG: An illustrative case-report that provides its recording
James A Reiffel
Journal of the American College of Cardiology
|
September 1, 2022
Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome
James A Reiffel
The American Journal of Cardiology
|
May 12, 2018
Back to the Future-New Data Confirms Old Data
James A Reiffel
American Heart Journal
|
May 1, 2022
The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy
James A Reiffel
JAMA
|
April 23, 2009
Equivalence of generic and brand-name drugs for cardiovascular disease
James A Reiffel
Journal of Atrial Fibrillation
|
May 13, 2017
GIANT Flutter Waves in ECG Lead V1: a Marker of Pulmonary Hypertension
James A Reiffel
Journal of Atrial Fibrillation
|
May 13, 2017
The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn
James A Reiffel
Current Opinion in Cardiology
|
December 23, 2003
Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?
James A Reiffel
Page
of 21